Arch Therapeutics Inc (ARTH)

[BooDog]

Excellent timing right before our 510(k). Excellent!!!!

Best to all of us!!


GO $ARTH

Message in reply to:

http://ir.archtherapeutics.com/press-releases/detail/497

Recent Arch study results demonstrate safety of AC5. Any positive news is always a good thing!

https://finance.yahoo.com/news/arch-therapeutics-reports-favorable-results-115500275.html

Arch Therapeutics Reports Favorable Results in Repeat Dose Testing of AC5™ for Subchronic Systemic Toxicity


GlobeNewswire•September 12, 2017

FRAMINGHAM, Mass., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices reported that AC5™ Topical Gel (AC5™) was found to be biocompatible in testing designed to investigate subchronic systemic toxicity. The subchronic systemic testing, which involved repeat, frequent dosing over 8 weeks, is one of a panel of biocompatibility evaluation endpoints recommended by US FDA regulatory guidelines for devices such as AC5 to allow use in humans.